Table 5

 Characteristics derived from measures at month 12 of the trial of the DESMOND intervention that were used as inputs for the long term model

Control (mean (SD) or n/N (%))Intervention (mean (SD) or n/N (%))
Age (years)61 (12)61 (12)
Sex (proportion male)26 910/50 000 (54)26 910/50 000 (54)
Smoking status (proportion who smoke)8129/50 000 (16.3)6294/50 000 (12.6)
High density lipoprotein cholesterol (mmol/l)1.231 (0.385)1.246 (0.385)
Total cholesterol (mmol/l)4.440 (0.967)4.399 (0.967)
Systolic blood pressure (mm Hg)133.74 (15.55)134.72 (15.55)
HbA1c level (%)6.64 (0.96)6.70 (0.96)
Ethnic origin
 White48 623/50 000 (97)48 623/50 000 (97)
 African-Caribbean467/50 000 (1)467/50 000 (1)
 Indian910/50 000 (2)910/50 000 (2)
Time since diagnosis (years)1 (0)1 (0)
Former smoker at diagnosis20 010/50 000 (40)20 543/50 000 (41)
Therapy at entry
 Diet and exercise29 868/50 000 (59.7)31 032/50 000 (62.1)
 Metformin16 283/50 000 (32.6)15 447/50 000 (30.9)
 Metformin and sulphonylurea combination3849/50 000 (7.7)3521/50 000 (7.0)

DESMOND, diabetes education and self management for ongoing and newly diagnosed; HbA1c, glycated haemoglobin.

Age and gender are the same in each arm because the aim of the modelling was to compare the long term effects of the DESMOND programme with the effects of the control intervention in the same cohort.